S
S Merger
Researcher at University of Ulm
Publications - 4
Citations - 84
S Merger is an academic researcher from University of Ulm. The author has contributed to research in topics: Diabetes mellitus & Medicine. The author has an hindex of 2, co-authored 2 publications receiving 55 citations.
Papers
More filters
Journal ArticleDOI
Prevalence and comorbidities of double diabetes
S Merger,Wolfgang Kerner,Marietta Stadler,Andrej Zeyfang,Peter M. Jehle,M. Müller-Korbsch,Reinhard W. Holl +6 more
TL;DR: Double diabetes seems to be an independent and important risk factor for persons with T1DM in developing macrovascular and microvascular comorbidities and patients should be identified and development of MS should be avoided.
Journal ArticleDOI
Are insulin analogues detemir or glulisine used preferentially in overweight/obese subjects? A German multicentre analysis of 38560 type 2 diabetic patients from the DPV registry.
Barbara Bohn,Nicole Scheuing,Peter M. Jehle,Katharina Laubner,B Born,S Merger,Michael Hummel,D Krakow,A Voll,A Zimmermann,Stefan Zimny,Reinhard W. Holl,Dpv,Apv initiatives +13 more
TL;DR: Detemir is used more often in overweight and obese patients compared to normal-weight patients, and the relationship is less pronounced for glulisine.
Journal ArticleDOI
Erratum: 100 Jahre Insulin: Wie hat sich die Insulintherapie bei Erwachsenen zwischen 2000 und 2021 verändert?
S Merger,Alexander Eckert,Peter Bramlage,G. Hess,Thomas Maak,Reinhard Welp,Christian Wagner,Markus Laimer,Peter M. Jehle,Reinhard W. Holl +9 more
TL;DR: In this paper , 100 Jahre Insulin: Wie hat sich die Insulintherapie bei Erwachsenen zwischen 2000 und 2021 verändert?
Journal ArticleDOI
100 Jahre Insulin: Wie hat sich die Insulintherapie bei Erwachsenen zwischen 2000 und 2021 verändert?
S Merger,Alexander Eckert,Peter Bramlage,G. Hess,Thomas Maak,Reinhard Welp,Christian Wagner,Markus Laimer,Peter M. Jehle,Reinhard W. Holl +9 more
TL;DR: In this article , a signifikante Verbesserung der Blutzuckereinstellung, aber vor allem eine Individualisierung der Diabetestherapie, is discussed.